NM_020184.4:c.1947C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020184.4(CNNM4):​c.1947C>T​(p.Ser649Ser) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0214 in 1,550,670 control chromosomes in the GnomAD database, including 449 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 24 hom., cov: 32)
Exomes 𝑓: 0.022 ( 425 hom. )

Consequence

CNNM4
NM_020184.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0001088
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.24

Publications

3 publications found
Variant links:
Genes affected
CNNM4 (HGNC:105): (cyclin and CBS domain divalent metal cation transport mediator 4) This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play a role in metal ion transport. Mutations in this gene are associated with Jalili syndrome which consists of cone-rod dystrophy and amelogenesis imperfecta. [provided by RefSeq, Feb 2010]
CNNM4 Gene-Disease associations (from GenCC):
  • Jalili syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-96799647-C-T is Benign according to our data. Variant chr2-96799647-C-T is described in ClinVar as Benign. ClinVar VariationId is 261212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.24 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0154 (2347/152334) while in subpopulation NFE AF = 0.0226 (1537/68032). AF 95% confidence interval is 0.0217. There are 24 homozygotes in GnomAd4. There are 1110 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNNM4NM_020184.4 linkc.1947C>T p.Ser649Ser splice_region_variant, synonymous_variant Exon 5 of 7 ENST00000377075.3 NP_064569.3 Q6P4Q7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNNM4ENST00000377075.3 linkc.1947C>T p.Ser649Ser splice_region_variant, synonymous_variant Exon 5 of 7 1 NM_020184.4 ENSP00000366275.2 Q6P4Q7-1
CNNM4ENST00000496186.5 linkn.621C>T splice_region_variant, non_coding_transcript_exon_variant Exon 5 of 6 3

Frequencies

GnomAD3 genomes
AF:
0.0154
AC:
2341
AN:
152216
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00528
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.0219
Gnomad ASJ
AF:
0.00779
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0147
Gnomad FIN
AF:
0.0101
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0226
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0168
AC:
2627
AN:
156836
AF XY:
0.0168
show subpopulations
Gnomad AFR exome
AF:
0.00478
Gnomad AMR exome
AF:
0.0244
Gnomad ASJ exome
AF:
0.00644
Gnomad EAS exome
AF:
0.0000880
Gnomad FIN exome
AF:
0.00974
Gnomad NFE exome
AF:
0.0216
Gnomad OTH exome
AF:
0.0178
GnomAD4 exome
AF:
0.0220
AC:
30809
AN:
1398336
Hom.:
425
Cov.:
31
AF XY:
0.0220
AC XY:
15176
AN XY:
689792
show subpopulations
African (AFR)
AF:
0.00415
AC:
131
AN:
31574
American (AMR)
AF:
0.0266
AC:
951
AN:
35728
Ashkenazi Jewish (ASJ)
AF:
0.00731
AC:
184
AN:
25174
East Asian (EAS)
AF:
0.0000839
AC:
3
AN:
35742
South Asian (SAS)
AF:
0.0168
AC:
1329
AN:
79222
European-Finnish (FIN)
AF:
0.0107
AC:
529
AN:
49334
Middle Eastern (MID)
AF:
0.00887
AC:
50
AN:
5640
European-Non Finnish (NFE)
AF:
0.0246
AC:
26484
AN:
1077944
Other (OTH)
AF:
0.0198
AC:
1148
AN:
57978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1405
2809
4214
5618
7023
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1038
2076
3114
4152
5190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0154
AC:
2347
AN:
152334
Hom.:
24
Cov.:
32
AF XY:
0.0149
AC XY:
1110
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00531
AC:
221
AN:
41584
American (AMR)
AF:
0.0220
AC:
336
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00779
AC:
27
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0147
AC:
71
AN:
4830
European-Finnish (FIN)
AF:
0.0101
AC:
107
AN:
10618
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0226
AC:
1537
AN:
68032
Other (OTH)
AF:
0.0133
AC:
28
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
122
243
365
486
608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0190
Hom.:
108
Bravo
AF:
0.0151
Asia WGS
AF:
0.0110
AC:
39
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jalili syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.11
DANN
Benign
0.77
PhyloP100
-4.2
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00011
dbscSNV1_RF
Benign
0.11
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41286594; hg19: chr2-97465384; COSMIC: COSV65662434; COSMIC: COSV65662434; API